These results demonstrate that Nrf2, a redox-sensitive transcription factor, has hepatic metabolic functions that have been linked to the pathogenesis of NAFLD/NASH. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.